NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)

The National Institutes of Health (NIH), including the Centers for Disease Control (CDC), and the Food and Drug Administration (FDA), intends to publish a Notice of Funding Opportunity (NOFO) to invite eligible United States small business concerns to submit Small Business Innovation Research (SBIR) grant applications. The goal of the SBIR program is to support scientific innovation and technological advancement, with a focus on commercialization. The program aims to stimulate technological innovation and product development by supporting research and development (R&D) in small businesses. Key areas of focus include various health-related topics, such as chronic diseases, environmental health, and infectious diseases. • The program provides funding for small businesses to conduct R&D and develop innovative products and services. • Eligible applicants are United States small business concerns, as defined by the Small Business Administration. • Applications are not being solicited at this time, but potential applicants are encouraged to begin considering applying for this new NOFO. • The program aims to support the development of products and services that can improve human health and quality of life. • The NOFO will utilize the R43/R44 activity code, and United States small businesses are encouraged to apply. • The program has various phases, including Phase I, Phase II, and Fast-Track, each with its own specific goals and requirements.